Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XJ0P
|
||||
Former ID |
DIB013245
|
||||
Drug Name |
BCX-140
|
||||
Synonyms |
BANA-113; BANA-153; BANA-205; BANA-206; BCX-140; Neuraminidase inhibitors, BioCryst
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Influenza virus [ICD10:J11.1] | Terminated | [1] | ||
Company |
BioCryst Pharmaceuticals Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C10H12N4O3
|
||||
Canonical SMILES |
c1(NC(=N)N)c(NC(=O)C)ccc(C(=O)O)c1
|
||||
CAS Number |
CAS 170447-93-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Neuraminidase | Target Info | Inhibitor | [2], [3] | |
KEGG Pathway | Other glycan degradation | ||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006335) | ||||
REF 2 | Neuraminidase inhibitors: zanamivir and oseltamivir. Ann Pharmacother. 2001 Jan;35(1):57-70. | ||||
REF 3 | CN patent application no. 104447481, Benzoic acid thiourea anti-influenza virus compounds as well as preparation method and use thereof. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.